Patients with Treatment-Resistant Depression
High-acuity patients with major depressive disorder who fail to respond to multiple antidepressant trials.
Frontiers in PsychiatryPatients with Treatment-Resistant Depression (TRD)
Ideas that could help Patients with Treatment-Resistant Depression
- Rapid-Response Depression Intervention (RRDI) Clinic
A specialized clinic model focusing on 'single-dose' high-impact interventions for treatment-resistant depression to achieve rapid symptom reduction.
Why it helps: Provides a faster path to remission for those who have failed multiple traditional medication trials.
- Non-Hallucinogenic TrkB Agonist
A pharmaceutical compound designed as a selective TrkB receptor agonist to induce neuroplasticity and antidepressant effects without activating 5-HT2A receptors. The approach focuses on mimicking BDNF-mediated resilience to stress while managing potential receptor interference and oncogenic risks.
Why it helps: Individuals who need the rapid neuroplasticity effects of psychedelics but cannot tolerate or are contraindicated for hallucinogenic experiences.